Role of VEGF/VEGFR autocrine in mediating EGFR TKI resistance in non-small cell lung cancer

被引：1
|
作者：
Osude, Chike [1 ]
Lin, Leo [1 ]
Foster, Brad [1 ]
Puri, Neelu [1 ]
机构：
[1] Univ Illinois, Coll Med Rockford, Rockford, IL USA
来源：
CANCER RESEARCH | 2018年 / 78卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2018-2595
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2595
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Management of acquired resistance to EGFR TKI–targeted therapy in advanced non-small cell lung cancer
    Shang-Gin Wu
    Jin-Yuan Shih
    Molecular Cancer, 17
  • [22] Investigation of AKT3 in the resistance of non-small cell lung cancer to EGFR-TKI
    Huang, Shih-Hsiang
    Shih, Jin-Yuan
    Chen, Ching-Chow
    CANCER RESEARCH, 2019, 79 (13)
  • [23] Primary TKI resistance in advanced non-small cell lung cancer with EGFR mutation: an open question
    Giuliani, Jacopo
    Martelli, Salvatore
    Remo, Andrea
    Bonetti, Andrea
    TUMORI, 2015, 101 (04) : E115 - E117
  • [24] The role of anti-EGFR therapies in EGFR-TKI-resistant advanced non-small cell lung cancer
    Ciardiello, Fortunato
    Hirsch, Fred R.
    Pirker, Robert
    Felip, Enriqueta
    Valencia, Christian
    Smit, Egbert F.
    CANCER TREATMENT REVIEWS, 2024, 122
  • [25] Association of integrin beta1 and c-MET in mediating EGFR TKI gefitinib resistance in non-small cell lung cancer
    Lixia Ju
    Caicun Zhou
    Cancer Cell International, 13
  • [26] Association of integrin beta1 and c-MET in mediating EGFR TKI gefitinib resistance in non-small cell lung cancer
    Ju, Lixia
    Zhou, Caicun
    CANCER CELL INTERNATIONAL, 2013, 13
  • [27] Long non-coding RNAs in non-small cell lung cancer: implications for EGFR-TKI resistance
    Liu, Detian
    Lu, Xiaolin
    Huang, Wentao
    Zhuang, Wei
    FRONTIERS IN GENETICS, 2023, 14
  • [28] Immune microenvironment change after acquiring resistance to EGFR TKI therapy in EGFR mutant non-small cell lung cancer
    Kim, Tae-Jung
    Kang, Jin-Hyoung
    Hong, Sook-hee
    MOLECULAR CANCER THERAPEUTICS, 2018, 17 (01)
  • [29] Apatinib enhances antitumour activity of EGFR-TKIs in non-small cell lung cancer with EGFR-TKI resistance
    Li, Fang
    Zhu, Tengjiao
    Cao, Baoshan
    Wang, Jiadong
    Liang, Li
    EUROPEAN JOURNAL OF CANCER, 2017, 84 : 184 - 192
  • [30] Inhitibing GRP78 in non-small cell lung cancer with acquired resistance to EGFR-TKI
    Park, Jaewoo
    Purushothaman, Baskaran
    Hong, Sera
    Choi, Munkyung
    Song, Joon Myong
    Kang, Keon Wook
    CANCER RESEARCH, 2023, 83 (07)
12345